Search

for
Search:

GlossaryFludarabine

chemotherapy drug treating chronic lymphocytic leukemia by inhibiting DNA synthesis

Fludarabine, also known as Fludara, is a chemotherapy medication used primarily to treat chronic lymphocytic leukemia (CLL). It works by interfering with the DNA synthesis of cancer cells, thereby inhibiting their growth and proliferation.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 53 results

research Permanent Diffuse Alopecia After Hematopoietic Stem Cell Transplantation in Childhood

16 citations, March 2017 in “Bone Marrow Transplantation”

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Rapid Full Engraftment and Successful Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Conditioning in Omenn Syndrome

research Rapid Full Engraftment and Successful Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Conditioning in Omenn Syndrome

8 citations, August 2009 in “Pediatric transplantation”

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

research Permanent Chemotherapy-Induced Nonscarring Alopecia and Premature Ovarian Failure

5 citations, March 2015 in “Clinical and Experimental Dermatology”

Chemotherapy caused a woman's permanent hair loss and early menopause.

research Categorization of Long-Lasting Hair Changes in Patients After Hematopoietic Stem Cell Transplants

August 2018 in “Journal of the American Academy of Dermatology”

Patients often experience long-lasting changes to their hair after stem cell transplants.

research Castleman's Disease Combined with the Development of Systemic Lupus Erythematosus

3 citations, June 2013 in “Turkish Journal of Rheumatology”

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

View more "fludarabine" in research →

Community Join

0 / 0 results

— no results